- KR₩67bn
- KR₩74bn
- KR₩148bn
Annual income statement for ICD Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 308,965 | 115,769 | 150,945 | 62,274 | 147,616 |
Cost of Revenue | |||||
Gross Profit | 84,183 | 23,723 | 16,009 | -7,439 | -3,137 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 258,897 | 117,743 | 160,773 | 101,782 | 177,662 |
Operating Profit | 50,068 | -1,973 | -9,828 | -39,508 | -30,046 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 42,615 | 427 | -5,342 | -45,714 | -21,390 |
Provision for Income Taxes | |||||
Net Income After Taxes | 33,459 | 762 | -5,419 | -41,318 | -28,302 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 33,459 | 762 | -5,419 | -41,318 | -28,291 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 33,624 | 762 | -5,419 | -41,318 | -28,291 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1,972 | 184 | -145 | -2,560 | -1,604 |
Dividends per Share |